HEALTHCARE WORKER’S ROLE IN IDENTIFYING POTENTIAL INTERACTIONS BETWEEN HERBAL MEDICATIONS AND CONVENTIONAL DRUGS

Main Article Content

Mamdouh Saad Alhumaidi
Fahad Matuq Almalki
Abdullah Mayudh Alsayyali
Ghazi Abdullah Alshamrani
Abdulrahman Zayed Alotaibi
Abed Ayed Al Gethami
Mona Ali Alqarni
Mohammed Ali Alqarni
Sameer Abed Alhosayni
Omar Moidh Alsukhayri
Iman Saud Aljabry
Khaled Ali Alamri
Abdullah Ahmed Aljohani

Keywords

pharmacists, herbal medications, drug interactions, patient safety, healthcare decisions, conventional drugs.

Abstract

Herbal medications, sourced from plants, have been used across various cultures for their potential healing properties. Often seen as natural and safe alternatives to conventional pharmaceuticals, these remedies are frequently incorporated into daily routines without considering potential interactions with prescribed medications. Common herbal medications include Echinacea, Ginkgo biloba, St. John's Wort, Turmeric (curcumin), Garlic, Ginseng, and Milk thistle, each with its specific uses. Despite their long history of use, the safety and effectiveness of these herbs can vary, and not all are backed by solid scientific evidence. All healthcare workers play a crucial role in ensuring patient safety and optimal therapeutic outcomes by identifying and managing drug interactions with herbal medications. Their responsibilities include reviewing medications, assessing risks, educating patients, and maintaining accurate documentation. Interactions between herbal medications and conventional drugs can affect drug absorption, distribution, metabolism, and excretion. Healthcare professionals assess these interactions based on various factors, including patient characteristics and scientific evidence, and educate patients about the risks and benefits of combining herbal and conventional treatments. They also communicate with healthcare teams, report adverse events, and ensure treatment continuity during transitions of care. In summary, all healthcare workers are instrumental in recognizing, assessing, and managing potential interactions between herbal medications and conventional drugs, ensuring patient safety, effective treatment, and informed healthcare decisions in the complex healthcare landscape.

Abstract 455 | PDF Downloads 151

References

1. Lexicomp. Drug Interactions. [Internet]. Wolters Kluwer. 2022 [cited 2024 Mar 14]. Available from: https://www.wolterskluwercdi.com/lexicomp-online/.
2. Hansten PD, Horn JR. The Top 100 Drug Interactions: A Guide to Patient Management. 2022 Edition. H&H Publications; 2022.
3. Stockley IH. Stockley's Drug Interactions. 12th ed. London: Pharmaceutical Press; 2021.
4. Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, et al. Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East Macedonia and Thrace, Greece. J Clin Pharm Ther. 2014;39(4):377-83.
5. Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51.
6. Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Junior DP, Pilger D, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012 Dec;68(12):1667-76.
7. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB; Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug-drug interactions in the elderly. Ann Pharmacother. 2002 Nov;36(11):1675-81.
8. Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12(3):266-72.
9. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003 Apr 2;289(13):1652-8.
10. Patel RI, Beckett RD. Evaluation of resources for analyzing drug interactions. J Med Libr Assoc. 2016 Oct;104(4):290-5.
11. Hansten PD, Horn JR. Drug interactions analysis and management. St. Louis, MO: Wolters Kluwer Health; 2012.
12. Juurlink DN. Drug interactions: what clinicians need to know. CMAJ. 2011;183(8):927-929.
13. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003). 2004;44(2):142-151.
14. Tannenbaum C, Sheehan NL. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2014;82(1):10-26.
15. Flockhart DA. Drug interactions: Cytochrome P450 drug interaction table. Indiana University School of Medicine; 2007. Available from: https://drug-interactions.medicine.iu.edu/ MainTable.aspx
16. Obreli-Neto PR, Nobili A, de Lyra DP Jr, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68(12):1667-1676.
17. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003). 2004;44(2):136-141.

Most read articles by the same author(s)